000 05428nam a22005775i 4500
001 978-3-031-59475-5
003 DE-He213
005 20251030112615.0
007 cr nn 008mamaa
008 240705s2024 sz | s |||| 0|eng d
020 _a9783031594755
_9978-3-031-59475-5
024 7 _a10.1007/978-3-031-59475-5
_2doi
050 4 _aRM270-282
072 7 _aMJCM
_2bicssc
072 7 _aMED044000
_2bisacsh
072 7 _aMJCM
_2thema
245 1 4 _aThe Basics of Cancer Immunotherapy
_h[electronic resource] /
_cedited by Haidong Dong, Svetomir N. Markovic.
250 _a2nd ed. 2024.
264 1 _aCham :
_bSpringer International Publishing :
_bImprint: Springer,
_c2024.
300 _aXIII, 221 p. 20 illus., 19 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
505 0 _aThe basic concepts in cancer immunology and immunotherapy -- Immune checkpoint inhibitors in oncology -- Bi-specific, T cell engaging antibodies including Tebentifusp -- Cell therapy for cancer: CAR-T, TIL -- Viral immunotherapy strategies in clinical practice: TVEC -- Chemotherapy for resistant cancer to ICI -- Radio-immunotherapy for refractory cancers -- Immunotherapy for melanoma and skin cancer -- Immunotherapy for lung cancer -- Immunotherapy for breast cancer -- Immunotherapy for genitourinary malignancies -- Immunotherapy for gastrointestinal malignancies -- Immunotherapy in the solid organ transplant recipient -- Management of immune-related adverse events from immune checkpoint inhibitor therapy -- Resources for patients undergoing immune therapy for cancer -- Immunotherapy for head and neck cancer.
520 _aThis comprehensively updated new edition provides patients and their physicians (especially non-oncologist healthcare providers) with a clear and concise introduction to cancer immunotherapy. Unlike traditional forms of cancer therapy, immunotherapy acts by boosting the patient’s own immune system to fight cancer; immunotherapy's unique features make its management, monitoring and side-effects different from those of traditional cancer therapy. Especially novel are the side effects of cancer immunotherapy, necessitating greater awareness for both patients and physicians in order to minimize complications and maximize benefits. The patient-friendly and state-of-the-art knowledge presented in this book will inform patients and their care providers about the benefits and risks of cancer immunotherapy, and help them to understand how immunotherapy would control their unique disease. Researchers and academic professionals in the field of cancer immunotherapy will also find clear, useful information to help them communicate with patients and address unresolved issues. Key features include: Expertise. Editors and authors are scientists and oncologists specializing in cancer immunotherapy, involved in scientific discovery from the early stage of immune-checkpoint inhibitors to today's patient care. Their insights, expertise and experience guarantee high quality and authority in the science, medicine and practice of cancer immunotherapy. Patient-friendly. This book is written specifically for cancer patients considering or undergoing immunotherapy. As an educational tool, this book will help the reader to understand the underlying science, balance the risks and benefits based on both research and clinical facts, and make an informed decision regarding their treatment options. Disease Specificity. Cancer is a complicated disease involving multiple stages and pathology. Its response to immunotherapy is individualized and varies depending on cancer types. The authors’ expertise in treating different types of cancers, including melanoma, lung, kidney, bladder, breast, and lymphoma, provides disease-specific insights in applying immunotherapy to each disease. State-of-the-Art. This edition has been comprehensively updated to reflect recent advances, including detailed coverage of the latest therapies like CAR-T, TIL, immune checkpoint inhibitors and bispecific T cell engaging antibodies, and dedicated chapters on breast cancer, solid organ transplant recipients, GI and genitourinary malignancies, and resistant cancer. .
650 0 _aImmunotherapy.
_969215
650 0 _aMedical sciences.
_965984
650 0 _aImmunology.
_969214
650 0 _aCancer
_xTreatment.
_963722
650 0 _aPatient education.
650 1 4 _aImmunotherapy.
_969215
650 2 4 _aHealth Sciences.
_965987
650 2 4 _aImmunology.
_969214
650 2 4 _aCancer Therapy.
_973414
650 2 4 _aPatient Education.
700 1 _aDong, Haidong.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_980083
700 1 _aMarkovic, Svetomir N.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_980084
710 2 _aSpringerLink (Online service)
773 0 _tSpringer Nature eBook
776 0 8 _iPrinted edition:
_z9783031594748
776 0 8 _iPrinted edition:
_z9783031594762
856 4 0 _uhttps://doi.org/10.1007/978-3-031-59475-5
912 _aZDB-2-SBL
912 _aZDB-2-SXB
999 _c61372
_d61372